Decreased immunoglobulin G levels after living-donor liver transplantation is a risk factor for bacterial infection and sepsis

Transpl Infect Dis. 2014 Apr;16(2):225-31. doi: 10.1111/tid.12188. Epub 2014 Mar 5.

Abstract

Background: Several studies have suggested an association between post-transplant immunoglobulin (Ig) levels and the development of infection in solid organ transplantation. We therefore conducted exploratory analyses of potential factors associated with bacterial infection/sepsis after living-donor liver transplantation (LDLT).

Methods: Blood samples from 177 recipients who received primary LDLT between September 1999 and November 2011 were available for study. Hypogammaglobulinemia was defined as having at least 1 IgG level <650 mg/dL within 7 days after LDLT. Risk factors for developing post-transplant bacterial infection and sepsis within 3 months after LDLT were analyzed.

Results: Fifty (28.2%) recipients experienced bacterial infection within 3 months of LDLT. Eighty-four (47.5%) recipients had hypogammaglobulinemia, although no recipients had hypogammaglobulinemia before LDLT. Hypogammaglobulinemia, undergoing hepaticojejunostomy, and portal pressure at closure >15 mmHg were independent risk factors for developing bacterial infection within 3 months of LDLT (P < 0.0001 P = 0.0008, and P = 0.011, respectively). The odds ratio (OR) and confidence interval (CI) for hypogammaglobulinemia were 4.79 and 2.27-10.7, respectively. Twenty-four (13.6%) recipients developed bacterial sepsis within 3 months. Hypogammaglobulinemia, operative time >14 h, model for end-stage liver disease score >15, and no mycophenolate mofetil use were independent risk factors for developing bacterial sepsis (P = 0.009, P = 0.001, P = 0.003, and P = 0.005, respectively). The OR and CI for hypogammaglobulinemia were 3.83 and 1.38-12.0, respectively.

Conclusions: Hypogammaglobulinemia within 7 days of LDLT was a significant risk factor for post-transplant bacterial infection and sepsis.

Keywords: hypogammaglobulinemia; living-donor liver transplantation; sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Agammaglobulinemia / complications*
  • Anastomosis, Surgical / adverse effects
  • Bacterial Infections / immunology*
  • End Stage Liver Disease / physiopathology
  • Female
  • Hepatic Duct, Common / surgery*
  • Humans
  • Hypertension, Portal / complications
  • Immunoglobulin G / blood*
  • Immunosuppressive Agents / therapeutic use
  • Jejunum / surgery*
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Operative Time
  • Retrospective Studies
  • Risk Factors
  • Sepsis / immunology*
  • Severity of Illness Index
  • Time Factors

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents
  • Mycophenolic Acid